ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.

Lauren Averett Byers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.